Managing Epilepsy After Initial Treatment Fails - MOC Section 1
This accredited eCME is directed to community neurologists in the therapeutic area of epilepsy in adults. Epilepsy is one of the most common neurological diseases globally with over 50 million people affected worldwide. The World Health Organization estimates that 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. About 50% of newly diagnosed patients become seizure-free on the first antiepileptic drug (AED), leaving a substantial population of people who still experience seizures. Repetitive seizures are associated with an increased risk of high morbidity rates and reduced health-related quality of life. The three main goals of treatment include controlling seizures, avoiding treatment side effects, and maintaining or restoring quality of life.
The program reviews factors critical to the success of antiepileptic drug choice such as patient factors; therapeutic spectrum, mechanisms of action, side effects and adverse events of AEDs; and other special considerations. How to determine treatment success or failure is presented, and approaches are offered on how to switch or add therapies after treatment failure.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada, and is approved by the CPD Medicine Program, University of Manitoba for a maximum of 1 Hour. Participants should only claim credit for the actual number of hours attended. The University of Manitoba CPD Medicine Program is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME). This program has been reviewed and developed by The University of Manitoba. This program has been reviewed and developed by the International Centre for Evidence-Based Medicine (ICEBM) Canada.
|S. Nizam Ahmed, MD,
Seyed M. Mirsattari, MD, PhD, FRCPC
Garima Shukla, MBBS, MD, DM